Clinical Trials for Radioactive Iodine-refractory, Differentiated Thyroid Cancer With NRAS Mutation

Find clinical trials for radioactive iodine-refractory, differentiated thyroid cancer with nras mutation. Discover research opportunities and treatment options in your area.

1 Active Trial Found

Showing 1 trial on this page

Page 1 of 1

Phase II Trial of Tunlametinib in NRAS-Mutant Advanced Thyroid Cancer

NCT ID: NCT06970353

This clinical trial is studying a new treatment called Tunlametinib for patients with a specific type of thyroid cancer that has a genetic change known as an NRAS mutation. The aim is to see if Tun...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Shanghai, , China

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions